about
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hyperte...
Read More
40.59
-0.48
(-1.17%)
2.0M
XNAS Volume
XNAS 23 Jan, 2026 4:30 PM (EST)
Low Financial Strength
Expensive Valuation
Technically Bullish
Momentum Trap
These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution
View Similar
Embed DVM
Liquidia Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..